# Stimuli-Responsive Hydrogels: From Swelling–Deswelling Mechanisms to Biomedical Applications

**Authors:** Meyoung-Kon Kim, Junghan Lee, A-Ram Kang

PMC · DOI: 10.3390/nano16050329 · Nanomaterials · 2026-03-05

## TL;DR

Smart hydrogels that change shape in response to stimuli are being developed for biomedical uses like drug delivery and tissue engineering.

## Contribution

The paper reviews recent innovations in smart hydrogels, focusing on improved swelling-deswelling behavior and biomedical applications.

## Key findings

- Novel hydrogel designs with enhanced stimulus sensitivity and biocompatibility have been developed.
- Strategies like reducing particle size and engineering porous structures can improve response rates.
- Smart hydrogels are being applied in drug release, gene delivery, biosensors, and tissue engineering.

## Abstract

Stimuli-responsive hydrogels, also referred to as “smart” hydrogels, have emerged as versatile platforms for a wide range of biological and biomedical applications owing to their tunable physical, chemical, and biocompatible properties. Their adaptability arises from both their ability to undergo reversible swelling–deswelling and volume phase transitions in response to specific physicochemical or biological stimuli and the diversity of synthesis strategies that enable precise tailoring of material properties to meet distinct biomedical demands. Recent advances have led to the development of novel hydrogel designs with improved swelling–deswelling behavior, enhanced stimulus sensitivity, and superior biocompatibility, thereby expanding their applicability in complex biological environments. Despite this progress, challenges such as precise control over hydrogel size and relatively slow response kinetics remain critical barriers to broader biomedical and clinical translation. Addressing these limitations requires strategies, including reducing hydrogel particle dimensions to accelerate response rates and engineering heterogeneous or highly porous gel architectures to increase functional surface area. This review provides a comprehensive classification of stimuli-responsive hydrogels based on their physical properties and response mechanisms, and summarizes recent innovations in their design, synthesis, and biomedical applications. Furthermore, it discusses emerging approaches to enhance the clinical applicability of smart hydrogels in controlled drug release, targeted gene delivery, biosensor development, and tissue engineering. Overall, continued optimization of swelling–deswelling characteristics and material design will be essential to fully realize the potential of stimuli-responsive hydrogels in precision medicine and advanced therapeutic applications.

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CCNB1 (cyclin B1) [NCBI Gene 891] {aka CCNB}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, HAO1 (hydroxyacid oxidase 1) [NCBI Gene 54363] {aka GO, GOX, GOX1, HAOX1}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}
- **Diseases:** tumor (MESH:D009369), swelling (MESH:D004487), injury to (MESH:D014947), LCST (MESH:D016638), cytotoxicity (MESH:D064420)
- **Chemicals:** gluconic acid (MESH:C030691), rhodamine B (MESH:C029773), H2O2 (MESH:D006861), MC (MESH:D008747), poly (ethylene glycol) (MESH:D011092), COO (MESH:C041069), OH- (MESH:C031356), polyaniline (MESH:C416807), BA (MESH:D001897), ST (MESH:D020058), PEGDA (MESH:C437167), glycerophosphate (MESH:D005994), PMMA (MESH:D019904), H2O. (MESH:D014867), fluorescein sodium (MESH:D019793), PAAm (MESH:C016679), Glucose (MESH:D005947), PBA (MESH:C010686), PDEA (MESH:C092301), poly(GEMA)- (MESH:C090633), PMAA (MESH:C030613), oligonucleotides (MESH:D009841), methacrylate (MESH:D008689), cellulose (MESH:D002482), Alginate (MESH:D000464), graphene (MESH:D006108), acrylate (MESH:C036658), GO (MESH:C000628730), amine (MESH:D000588), carbohydrates (MESH:D002241), alpha-CD (MESH:C032613), PDEAAm (MESH:C428028), oxygen (MESH:D010100), acrylamide (MESH:D020106), poly(amine) (MESH:D011073), hydrogen (MESH:D006859), PNIPAAm (MESH:C052970), calcium (MESH:D002118), Biomolecule (-), polymer (MESH:D011108), Ibuprofen (MESH:D007052), angiopep-2 (MESH:C531860), EDTA (MESH:D004492), gossypol (MESH:D006072), PHT (MESH:D010672), PAAc (MESH:C006903), doxorubicin (MESH:D004317), gold (MESH:D006046), polysaccharide (MESH:D011134), poly(organophosphazene) (MESH:C515246), Arg-Gly-Asp (MESH:C047981), polyelectrolytes (MESH:D000071228), chitosan (MESH:D048271), platinum (MESH:D010984), adenosine (MESH:D000241), CS (MESH:D002586)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12986877/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12986877/full.md

## References

109 references — full list in the complete paper: https://tomesphere.com/paper/PMC12986877/full.md

---
Source: https://tomesphere.com/paper/PMC12986877